Summary

Persistence Market Research has recently published an extensive report on the global Whole Genome Sequencing (WGS) Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

• Whole Genome Sequencing Market Size (2024E): USD 1.5 Bn
• Projected Market Value (2031F): USD 6.7 Bn
• Global Market Growth Rate (CAGR 2024 to 2031): 20.3%

Whole Genome Sequencing Market - Report Scope:

The Whole Genome Sequencing Market encompasses a variety of instruments, consumables, and services used in sequencing techniques. WGS plays a crucial role in precision medicine, helping researchers and clinicians to decode the complete genetic makeup of organisms, including humans. The market is driven by its application in clinical diagnostics, research, and agriculture, and is increasingly being adopted in hospitals, research institutes, and biotechnology companies. Growth in this market is primarily driven by the rising prevalence of genetic disorders and cancers, advancements in sequencing technologies, and increasing demand for personalized medicine.

Market Growth Drivers:

The global Whole Genome Sequencing Market is driven by several key factors, including the growing need for early detection of genetic disorders and cancers, which has led to increased adoption of WGS in clinical diagnostics. The technology allows for comprehensive detection of genetic mutations, enabling precision medicine approaches that are tailored to the individual's genetic profile. Additionally, advancements in next-generation sequencing (NGS) technologies, which have significantly reduced the cost and time required for sequencing, have further fueled market growth. The integration of WGS with other omics data, as well as its application in prenatal screening and pharmacogenomics, is expanding its use in personalized healthcare solutions.

Market Restraints:

Despite its rapid growth, the Whole Genome Sequencing Market faces challenges, including the high cost of sequencing equipment and services, especially in price-sensitive regions. Additionally, the complexity of data interpretation and the need for advanced bioinformatics tools to analyze sequencing results can be a barrier for widespread adoption. Regulatory and ethical concerns surrounding the use of genomic data, particularly in clinical settings, also pose challenges to market growth. In emerging markets, the lack of adequate infrastructure and skilled professionals further limits the adoption of WGS technologies.

Market Opportunities:

The Whole Genome Sequencing Market presents significant growth opportunities, driven by the increasing application of WGS in precision medicine and personalized healthcare. As the demand for targeted therapies grows, WGS is becoming an essential tool for clinicians and researchers in identifying genetic mutations associated with specific diseases. The rising trend of integrating WGS data with other omics data, such as proteomics and metabolomics, offers new insights into complex biological systems and diseases, creating opportunities for market expansion. Additionally, the development of portable and lower-cost sequencing devices is expected to boost adoption in smaller healthcare settings and research institutions.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Whole Genome Sequencing Market globally?
• Which segments are leading the market in terms of product type and application?
• How are technological advancements influencing the competitive landscape of the Whole Genome Sequencing Market?
• Who are the key players in the Whole Genome Sequencing Market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Whole Genome Sequencing Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Whole Genome Sequencing Market focus on technological innovation, product differentiation, and strategic collaborations to maintain a competitive edge. Companies invest heavily in research and development to improve sequencing accuracy, speed, and cost-effectiveness. Collaborations with research institutes, hospitals, and biotechnology firms help expand market access and foster product adoption. Market leaders are also working on developing more affordable sequencing solutions to meet the growing demand for WGS in clinical and research settings.

Key Market Players

• Thermo Fisher Scientific, Inc
• Danaher Corporation
• Illumina, Inc
• QIAGEN N.V.
• Merck KGaA
• Eurofins Scientific
• Siemens Healthineers
• Macrogens, Inc
• Bio-Rad Laboratories, Inc
• Agilent Technologies, Inc
• F. Hoffmann-La Roche Ltd.

Whole Genome Sequencing Market Segmentation

By Product

• Instruments
• Consumables
• Services

By Type

• Large Whole Genome Sequencing
• Small Whole Genome Sequencing

By Workflow

• Pre-sequencing
• Sequencing
• Data Analysis

By Region

• North America
• Latin America
• Europe
• South Asia & Oceania
• East Asia
• The Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Whole Genome Sequencing Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Technology Assessment
3.3. Regulatory Landscape
3.4. Value Chain Analysis
3.5. Key Deals and Mergers
3.6. PESTLE Analysis
3.7. Porter’s Five Force Analysis
4. Price Trend Analysis, 2019-2031
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Pricing Analysis, By Product
4.4. Regional Prices and Product Preferences
5. Global Whole Genome Sequencing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
5.1. Key Highlights
5.1.1. Market Size (US$ Bn) and Y-o-Y Growth
5.1.2. Absolute $ Opportunity
5.2. Market Size (US$ Bn) Analysis and Forecast
5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
5.3. Global Whole Genome Sequencing Market Outlook: Product
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2023
5.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
5.3.3.1. Instruments
5.3.3.2. Consumables
5.3.3.3. Services
5.4. Market Attractiveness Analysis: Product
5.5. Global Whole Genome Sequencing Market Outlook: Type
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Bn) Analysis, By Type, 2019-2023
5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024-2031
5.5.3.1. Large Whole Genome Sequencing
5.5.3.2. Small Whole Genome Sequencing
5.6. Market Attractiveness Analysis: Type
5.7. Global Whole Genome Sequencing Market Outlook: Workflow
5.7.1. Introduction / Key Findings
5.7.2. Historical Market Size (US$ Bn) Analysis, By Workflow, 2019-2023
5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2024-2031
5.7.3.1. Pre-sequencing
5.7.3.2. Sequencing
5.7.3.3. Data Analysis
5.8. Market Attractiveness Analysis: Workflow
6. Global Whole Genome Sequencing Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
6.3. Current Market Size (US$ Bn) (Units) Analysis and Forecast, By Region, 2024-2031
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Whole Genome Sequencing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
7.3.1. By Country
7.3.2. By Product
7.3.3. By Type
7.3.4. By Workflow
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
7.4.1. U.S.
7.4.2. Canada
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
7.5.1. Instruments
7.5.2. Consumables
7.5.3. Services
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024-2031
7.6.1. Large Whole Genome Sequencing
7.6.2. Small Whole Genome Sequencing
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2024-2031
7.7.1. Pre-sequencing
7.7.2. Sequencing
7.7.3. Data Analysis
7.8. Market Attractiveness Analysis
8. Europe Whole Genome Sequencing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
8.3.1. By Country
8.3.2. By Product
8.3.3. By Type
8.3.4. By Workflow
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
8.4.1. Germany
8.4.2. France
8.4.3. U.K.
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Turkey
8.4.8. Rest of Europe
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
8.5.1. Instruments
8.5.2. Consumables
8.5.3. Services
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024-2031
8.6.1. Large Whole Genome Sequencing
8.6.2. Small Whole Genome Sequencing
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2024-2031
8.7.1. Pre-sequencing
8.7.2. Sequencing
8.7.3. Data Analysis
8.8. Market Attractiveness Analysis
9. East Asia Whole Genome Sequencing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
9.3.1. By Country
9.3.2. By Product
9.3.3. By Type
9.3.4. By Workflow
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
9.4.1. China
9.4.2. Japan
9.4.3. South Korea
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
9.5.1. Instruments
9.5.2. Consumables
9.5.3. Services
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024-2031
9.6.1. Large Whole Genome Sequencing
9.6.2. Small Whole Genome Sequencing
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2024-2031
9.7.1. Pre-sequencing
9.7.2. Sequencing
9.7.3. Data Analysis
9.8. Market Attractiveness Analysis
10. South Asia & Oceania Whole Genome Sequencing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
10.3.1. By Country
10.3.2. By Product
10.3.3. By Type
10.3.4. By Workflow
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
10.4.1. India
10.4.2. Southeast Asia
10.4.3. ANZ
10.4.4. Rest of South Asia & Oceania
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
10.5.1. Instruments
10.5.2. Consumables
10.5.3. Services
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024-2031
10.6.1. Large Whole Genome Sequencing
10.6.2. Small Whole Genome Sequencing
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2024-2031
10.7.1. Pre-sequencing
10.7.2. Sequencing
10.7.3. Data Analysis
10.8. Market Attractiveness Analysis
11. Latin America Whole Genome Sequencing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
11.3.1. By Country
11.3.2. By Product
11.3.3. By Type
11.3.4. By Workflow
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
11.5.1. Instruments
11.5.2. Consumables
11.5.3. Services
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024-2031
11.6.1. Large Whole Genome Sequencing
11.6.2. Small Whole Genome Sequencing
11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2024-2031
11.7.1. Pre-sequencing
11.7.2. Sequencing
11.7.3. Data Analysis
11.8. Market Attractiveness Analysis
12. Middle East & Africa Whole Genome Sequencing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
12.1. Key Highlights
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
12.3.1. By Country
12.3.2. By Product
12.3.3. By Type
12.3.4. By Workflow
12.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
12.4.1. GCC Countries
12.4.2. Egypt
12.4.3. South Africa
12.4.4. Northern Africa
12.4.5. Rest of Middle East & Africa
12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
12.5.1. Instruments
12.5.2. Consumables
12.5.3. Services
12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024-2031
12.6.1. Large Whole Genome Sequencing
12.6.2. Small Whole Genome Sequencing
12.7. Current Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2024-2031
12.7.1. Pre-sequencing
12.7.2. Sequencing
12.7.3. Data Analysis
12.8. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2023
13.2. Market Structure
13.2.1. Competition Intensity Mapping by Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Thermo Fisher Scientific, Inc
13.3.1.1. Overview
13.3.1.2. Segments and Products
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Danaher Corporation
13.3.3. Illumina, Inc
13.3.4. QIAGEN N.V.
13.3.5. Merck KGaA
13.3.6. Eurofins Scientific
13.3.7. Siemens Healthineers
13.3.8. Macrogens, Inc
13.3.9. Bio-Rad Laboratories, Inc
13.3.10. Agilent Technologies, Inc
13.3.11. F. Hoffmann-La Roche Ltd.
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations